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Disruption of homeostasis between the host immune
system and the intestinal microbiota leads to inflam-
matory bowel disease (IBD). Whether IBD is insti-
gated by individual species or disruptions of entire
microbial communities remains controversial. We
characterized the fecal microbial communities in
the recently described T-bet/3Rag2/ ulcerative
colitis (TRUC) model driven by T-bet deficiency in
the innate immune system. 16S rRNA-based analysis
of TRUC and Rag2/ mice revealed distinctive
communities that correlate with host genotype.
The presence of Klebsiella pneumoniae and Proteus
mirabilis correlates with colitis in TRUC animals,
and these TRUC-derived strains can elicit colitis in
Rag2/ and WT adults but require a maternally
transmitted endogenous microbial community for
maximal intestinal inflammation. Cross-fostering
experiments indicated a role for these organisms
in maternal transmission of disease. Our findings
illustrate how gut microbial communities work in
concert with specific culturable colitogenic agents
to cause IBD.
INTRODUCTION
The human intestine is populated with up to 1012 microbes per
gram of lumenal contents. Coexistence with this microbial
community (microbiota) demands a well-regulated homeostasis
between the host immune system and the microbiota (Duerkop
et al., 2009; Hill and Artis, 2009). Inflammatory bowel disease
(IBD) can occur when this homeostasis is disrupted (Sartor,
2009). Whether individual pathogenic species or entire microbial
communities instigate inflammation still remains controversial292 Cell Host & Microbe 8, 292–300, September 16, 2010 ª2010 Els(Frank and Pace, 2008; Hansen et al., 2010). Defining features
of the microbiota and host that are associated with or initiate
IBD is critical.
In the absence of adaptive immunity, loss of the transcription
factor T-bet in conventionally raised T-bet/ 3 Rag2/
knockout mice results in a spontaneous and highly penetrant
colitis that shares histologic features with ulcerative colitis
in humans. T-bet/ 3 Rag2/ ulcerative colitis (TRUC) is
associated with altered colonic barrier function, elevated
TNF-a levels, and dysfunctional dendritic cells (DCs) (Garrett
et al., 2007, 2009). It is transmissible to WT hosts when they
are cross-fostered or cohoused with TRUC mice (Garrett
et al., 2007). TRUC mice provide an opportunity to probe the
host-microbe relationship in a model that displays both the
immunodeficiency and hyperimmunity observed in humans
with IBD.
Here, we show that the presence of Proteus mirabilis and
Klebsiella pneumoniae correlates with colitis in TRUC mice
and that TRUC-derived strains, in conjunction with an endoge-
nous microbial community, incite colitis in WT mice. These
studies revealed the utility of using both culture-independent
and -dependent approaches to interrogate the contribution of
community members to disease pathogenesis. This model also
provides a foundation for defining how gut microbial communi-
ties work in concert with specific culturable colitogenic agents
to cause IBD and creates an opportunity to evaluate preventative
or therapeutic measures directed at components of the gut
microbiota and/or host.RESULTS
16S rRNA-Based Time Series Analysis of TRUC versus
Rag2–/– Fecal Microbiota
A pilot experiment—using offspring of conventionally raised,
specified-pathogen-free (SPF) T-bet/3 Rag2/ and Rag2/
mothers—analyzed fecal samples collected from mothers at a
single time point and from their female pups (n = 3/genotype)evier Inc.
Figure 1. 16S rRNA-Based Time Series
Analysis of TRUC versus Rag2–/– Fecal
Microbiota
(A) Principal coordinates analysis (PCoA) of un-
weighted UniFrac distances from 2- to 10-week-
old TRUC (n = 3) andRag2/ (n = 3) mice and their
mothers. Host genotype influences microbial
community structure. Abbreviations: A, B, C, indi-
vidual pups colored by genotype, followed over
time (A.2, A.4, A.6, A.8, and A.10 refer to mouse
A sampled at 2, 4, 6, and 10 weeks of age).
(B) Distribution of order-level phylotypes in TRUC
and Rag2/ fecal microbial communities. Rela-
tive abundance (%) is plotted for each age group.
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independent survey of their fecal microbiota by multiplex
pyrosequencing of V2 region amplicons of bacterial 16S rRNA
genes (n = 32 samples; 2348 ± 343 reads/sample) analyzed
by principal coordinates analysis (PCoA) plots based on
unweighted UniFrac measurements disclosed a correlation
between host genotype and community phylogeny at all ages
surveyed (Figure 1A). A total of 69 species-level phylogenetic
types, belonging to four major bacterial phyla, exhibited signifi-
cant differences at various ages in the fecal communities of
mice of the two genotypes (Table S1). Compared to Rag2/
controls, TRUC mice had a significantly higher proportional
representation of species-level operational taxonomic units
(OTUs) belonging to the order Bacteroidales (phylum Bacteroi-
detes; p = 0.00643) and significantly lower proportional
representation of OTUs belonging to the orders Clostridiales
(phylum Firmicutes; p = 0.0201) and Deltaproteobacteria
(phylum Proteobacteria; p = 0.0299) (p values by Mann-Whitney
test with Bonferroni correction) (Figure 1B).Cell Host & Microbe 8, 292–300, SeK. pneumoniae and P. mirabilis
Correlate with the Presence
of Colitis in TRUC Mice
We also performed quantitative cultures
to obtain independent verification of
differences in bacterial burden for defined
species and to have culturable isolates
available to test the specific effects of
individual strains on disease initiation
and progression. A total of 57 bacterial
species were recovered and identified
from fecal pellets obtained from three
TRUC and three Rag2/ mice surveyed
at 2, 4, 6, 8, and 10 weeks of age
and from their mothers (Figure 2A and
Table S2).
Experiments administering oral antibi-
otics (Abx) helped further refine potential
classes of colitogenic commensal organ-
isms. Gentamicin (gent) or metronidazole
(metro) but not vancomycin (vanco) were
highly effective in ameliorating TRUC
colitis and resulted in clinically and statis-
tically significant changes in colitis scores
(mean colitis score 0.5 ± 0.52, p < 0.0001compared to water control) (Figure 2B). This result pointed us to
a role for Gram-negative facultative organisms in TRUC.
The in vitro Abx resistance profiles of the commensal strains
selectively recovered from TRUC but not Rag2/ fecal samples
(Figures 2A and 2B, lower panel) corresponded to the in vivo
Abx sensitivity of the colitis (Figure 2B, upper panel) since
K. pneumoniae and P. mirabilis, both facultative enterics, were
sensitive to gent but resistant to vanco (Figure 2B, lower panel).
A more extensive, culture-based survey of a larger number of
TRUC and Rag2/ mice to determine if these bacteria were
present in afflicted but absent from healthy mice revealed that
K. pneumoniae and P. mirabilis were culturable in all TRUC
mice tested (n = 126) at every time point (Figure 2C). In contrast,
both species were below our limit of detection (<4.4 log10 cfu/g
fecal material) in Rag2/ mice at each time point (Figure 2C).
We treated 4-week-old TRUC mice with Abx using the
protocol shown previously to ameliorate colitis and cultured
feces obtained 1 day before and 1 day after Abx administra-
tion. K. pneumoniae and P. mirabilis fecal levels fell below ourptember 16, 2010 ª2010 Elsevier Inc. 293
Figure 2. The Presence of K. pneumoniae and P. mirabilis Correlates with the Presence of Colitis in TRUC Mice
(A) Culture-based identification of bacteria present in fecal samples from Figure 1 mice and time points. Species observed in >1 mouse or in 1 mouse at >1 time
point are shown. Summary of species-level differences in the fecal microbiota of TRUC versus Rag2/ mice is observed in the inset.
(B) Upper panel: In vivo Abx sensitivities of TRUC colitis. Each dot represents one mouse treated for 4 weeks with the indicated Abx. VMNA: vanco, metro,
neomycin, and ampicillin. Horizontal bars represent the mean. p value% 0.0001 by Mann-Whitney test. Lower panel: Summary of in vitro Abx sensitivities for
species selectively detected in TRUC fecal microbiota.
(C) Culture-based survey of Gram-negative aerobes in fecal samples from TRUC (shaded circles) and Rag2/ (open circles) at 2–20 weeks of age.
(D) In vivo sensitivity of K. pneumoniae (squares) and P. mirabilis (circles), as defined by culture-based surveys of TRUC fecal samples collected 1 day before
(shaded symbol) and 1 day after (open symbol) Abx treatment. Each dot represents data from a fecal sample obtained from onemouse. Horizontal bars represent
the mean value.
(E) FISH using an Oregon-Green 488-conjugated ‘‘universal bacterial’’ 16S rRNA-directed oligonucleotide probe (EUB338) demonstrates the presence of
bacteria in the mucus layer and directly adjacent to the epithelium in TRUC mice. Upper panels, TRUC; lower panels, Rag2/. A 10 mm scale bar for the panel
is shown in the lower left of the first image.
(F) Enterobacteriaceae (red), Klebsiella (red), and Proteus (red) were visualized adjacent to the epithelium in TRUCmice using Fluor-conjugated 16S rRNA or 23S
rRNA oligonucleotide probes (pB-00914 [Enterobacteriaceae], pB-00352 [Klebsiella pneumonia], pB-02110 [Proteus mirabilis]). Sections were also hybridized
with the EUB338 universal bacterial probe (green). Scale bars (10 mm) are shown for each image.
(G) Enterobacteriaceae (red), Klebsiella (red), and Proteus (red) probe signals are seen adjacent to or along the epithelium in TRUCmice. Epithelial cell nuclei were
stained with DAPI. White star symbols mark bacteria in (F) and (G). Scale bars (10 mm) are shown for each image.
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The Gut Microbiota and TRUC Colitislimit of detection when mice were treated with gent or metro,
but treatment with vanco neither abolished colitis nor reduced
levels of these bacteria (Figure 2D).
To test the hypothesis that K. pneumoniae and P. mirabilis
play a role in TRUC pathogenesis, we determined the physical
location of these species using 16S and 23S rDNA fluorescence
in situ hybridization (FISH) oligonucleotide probes on whole294 Cell Host & Microbe 8, 292–300, September 16, 2010 ª2010 Elscolonic sections. We focused on the degree of colonization in
the lumen, the mucus layer over the epithelium, and the mucosa.
As has been reported in IBD patients using a universal bacterial
16S rRNA FISH probe (Swidsinski et al., 2005), we observed that
the colonic mucus of colitic TRUC mice harbored numerous
bacteria and that there was a consistent loss of a ‘‘bacterial-
free zone’’ adjacent to the colonic epithelium (Figure 2E). Healthyevier Inc.
Cell Host & Microbe
The Gut Microbiota and TRUC Colitis(noncolitic) Rag2/ mice did not exhibit any of these pheno-
types (Figure 2E). Using a set of probeBase consortium 23S
and 16S rDNA probes to detect K. pneumoniae and P. mirabilis
(Loy et al., 2007), we visualized a small number of organisms
adjacent to the epithelium (Figures 2F and 2G). Hence, K. pneu-
monia and P. mirabilis may have invasive potential, or the
proximity of their bacterial products to the apical epithelial
surface may trigger inflammatory responses without frank inva-
sion. Either could explain their role in TRUC colitis, as access
to the mucosa would increase the opportunity for eliciting a
host proinflammatory response.K. pneumoniae and P. mirabilis Elicit Colitis but Require
a Maternally Transmitted Endogenous Microbial
Community for Maximal Intestinal Inflammation
Following postnatal exposure to a TRUC dam, WT and Rag2/
mice develop histopathologic features of colitis (penetrance of
phenotype:94%at8weeksof age) (Garrett et al., 2007).Weasked
if this maternally transmitted disease had a pattern of Abx sensi-
tivity similar to spontaneous TRUC colitis. We cross-fostered
TRUC, Rag2/, and WT pups on TRUC mothers who received
water, gent, metro, or vanco from preconception through wean-
ing. Gent and metro markedly improved the colitis score for all
mice in a statistically significant fashion, while vanco did not,
similar to what we observed in spontaneous TRUC colitis (n = 2
foster mothers/genotype; 2–4 pups/litter surveyed) (Figure 3A).
We cultured fecal samples from WT and Rag2/ mice that
developed transmissible colitis from cross-fostering (Figure 3B).
K. pneumoniae and P. mirabilis were detected in all fecal
samples obtained from 8-week-old TRUC-fostered Rag2/
and WT pups at levels comparable to age-matched TRUC-
fostered TRUCmice. In contrast, neither organismwas detected
in any control Rag2/-fostered Rag2/ or WT-fostered WT
animals (n = 2 foster mothers/genotype; 2–3 pups/litter
surveyed) (Figure 3B). Neither TRUC mice fostered on Rag2/
nor WT mothers had histologic evidence of colitis or K. pneumo-
niae or P. mirabilis at 8 weeks of age (Figures S2 and 3B).
The presence of K. pneumoniae and P. mirabilis in colitic
TRUC mice and TRUC fostered Rag2/ and WT mice and the
lack of detectable bacteria in the fecal microbiota of healthy
Rag2/, WT, and WT or Rag2/-fostered TRUC provided
additional evidence for an association between the presence
of these bacteria and colitis.
One possibility is that the presence of K. pneumoniae and
P. mirabilis is a consequence rather than a cause of inflamma-
tion. Intestinal inflammation caused by Citrobacter rodentium
may drive blooms of Enterobacteriaceae, although this result is
controversial (Hoffmann et al., 2009; Lupp et al., 2007). To inves-
tigate the effects of inflammation on intestinal colonization by
K. pneumoniae and P. mirabilis, we treated 8-week-old WT
and Rag2/ mice with the mucosal toxin dextran sulfate
sodium to induce colitis (n = 8 mice/genotype). We did not
detect culturableK. pneumoniae orP.mirabilis in the fecal micro-
biota of any of these mice during our period of surveillance
(n = 8 mice/genotype; samples collected before and 1 day after
completion of a 1week treatment) (Figure S1), arguing against an
inflammatory response causing expansion of K. pneumoniae
and P. mirabilis in the TRUC gut microbiota.Cell Host &To directly test the colitogenic potential of K. pneumoniae and
P. mirabilis, we rederived conventionally raised TRUC mice as
germ-free and cocolonized the mice with these two Enterobac-
teriaceae at 8 weeks of age for 8 weeks (n = 5 mice). Both
organisms established themselves in the guts of all recipients
(mean value 1011.29 ± 0.46 cfu/microbial species/g dry weight
of feces; assayed 48 hr and weekly after the initial gavage)
(Figure S2). Colonic inflammation did not develop in these
cocolonized gnotobiotic TRUC mice, suggesting that interac-
tions among K. pneumoniae, P. mirabilis, and other members of
a gut microbial community are required to ignite the immunoin-
flammatory cascade that leads to colitis. To evaluate this possi-
bility, we colonized 2 week SPF WT and Rag2/ mice with
K. pneumoniae, P. mirabilis, or a combination of K. pneumoniae
and P. mirabilis (recovered from feces from the female TRUC
mother in Figure 2A and administered by direct oral instillation
of 107 cfu and by addition of 107 cfu to the drinking water every
other day for 8 weeks; n = 5–18 mice/treatment group). Control
groups of mice received a TRUC-derived E. coli strain. Both
K. pneumoniae and P. mirabilis established themselves in the
gutmicrobiota of bothRag2/ andWT (as defined by cfu assays
of feces obtained 2 days after the completion of 8 weeks of
treatment [Figure 3C]). Feces fromWTandRag2/hosts contain
E. coli, but we did not have the tools to distinguish these indige-
nous strains from the exogenously administered TRUC-associ-
ated E. coli strain. While no colonic inflammation was observed
after inoculation with E. coli (Figure 3D), treatment with P. mirabi-
lis, K. pneumoniae, or a combination of the two organisms
induced inflammation in both WT and Rag2/mice, with colitis
severity being significantly greater in Rag2/ mice exposed to
both species compared to P. mirabilis alone (Figure 3D). We
conclude that two Enterobacteriaceae, in concert with members
of themicrobiota, are able to elicit colitis, even in mice not genet-
ically predisposed to developing immunopathologic responses.
The penetrance and severity of colitis observed in the cocolo-
nization experiments with K. pneumoniae and P. mirabilis
were decreased compared to that observed in the spontaneous
TRUC model (e.g., Figure 2C) and in neonatal cross-fostering
experiments (TRUC-fostered Rag2/ mean colitis score 5.6 ±
1.14 and TRUC-fostered WT 3.17 ± 0.75) (Figure 3A). Instead,
it resembled experiments where adult TRUC mice were co-
housed with adult Rag2/ or WT mice (Garrett et al., 2007),
speaking to a possible role of maternal/foster bacterial and
nonbacterial factors in structuring microbial communities in the
neonate. Consistent with this, we found that TRUC milk has
a proinflammatory cytokine profile (Figure S5) and that the
microbiota of 2-week-old TRUC mice clusters in a distinct
group, as judged by PCoA plots of UniFrac measurements of
16S rRNA-defined communities (Figure 1A).
K. pneumoniae and P. mirabilis Colonization Patterns
Change in Response to Immunotherapy, and Both
Strains Induce TNF-a Production in T-bet–/– Rag2–/–
MyD88–/– Bone Marrow-Derived DCs
We next asked whether K. pneumoniae and P. mirabilis
colonization patterns might change in response to two immuno-
therapeutic interventions previously shown to cure TRUC colitis,
i.e., TNF-a neutralization and T-regulatory cell (T-reg) transfer
(Garrett et al., 2007). We used quantitative culture-basedMicrobe 8, 292–300, September 16, 2010 ª2010 Elsevier Inc. 295
Figure 3. K. pneumoniae and P. mirabilis Elicit Colitis but Require a Maternally Transmitted Endogenous Microbial Community for Maximal
Intestinal Inflammation
(A) The Abx sensitivities of colitis transmitted via TRUC cross-fostering are the same as spontaneous TRUC colitis. Abx-treated pregnant TRUC females were
used as foster mothers and treated with Abx in their water until weaning. Histologic colitis scores are shown for the fostered mice at 8 weeks of age.
(B) K. pneumoniae (squares) and P. mirabilis (circles) are detected in the fecal microbiota of TRUC cross-fosteredRag2/ andWTmice at 8 weeks of age but not
in 8-week-old TRUCmice fostered byRag2/ orWTmice. TRUC-fostered TRUC,Rag2/-fosteredRag2/, andWT-fosteredWT are shown as controls. Limits
of detection: 104.4 cfu/g dry weight of feces. Each symbol represents a fecal sample from a different mouse.
(C) Left panel: Fecal bacterial counts for cocolonized gnotobiotic TRUCmice. Mean values ± 1 SD are shown for K. pneumoniae (squares) andP.mirabilis (circles)
(n = 5 mice). Right panel: Histologic colitis scores of germ-free TRUC and germ-free TRUCmice cocolonized with K. pneumoniae and P. mirabilis from the TRUC
mother in Figure 1.
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The Gut Microbiota and TRUC Colitismethods to assay K. pneumoniae and P. mirabilis levels in feces
prior to treatment of 4-week-old TRUC mice with anti-TNF-a,
during weekly treatment for 4 weeks, and for 6 weeks after the
last dose (Figure 4A) (n = 10 mice, anti-TNF-a; n = 10, isotype
control) (histologic colitis scores in Figure S3). Significant differ-
ences in fecal K. pneumoniae levels between the TNF-a neutral-
ization and isotype control groups were observed after 7 weeks
of treatment (age 11 weeks; p = 0.0172; Mann-Whitney test) and
for P. mirabilis after a shorter period of treatment (p = 0.008, p =
0.0012, p = 0.0004, and p = 0.0403 at 7, 8, 9, and 10 weeks of
age). Two-way ANOVA revealed that anti-TNF-a neutralization
accounted for 10.7% of the total variance observed in fecal P.
mirabilis levels (adjusting for matching: F = 22.83, DFn = 1,
DFd = 18, p = 0.0002). TNF-a did not directly affect the growth
kinetics of either K. pneumoniae or P. mirabilis under in vitro
monoculture conditions (Figure S4).
We performed a similar analysis in TRUC mice that had
received 75,000 purified WT T-reg cells at 4 weeks of age (histo-
logic colitis scores at 12 weeks of age in Figure S3). Surprisingly,
while T-reg infusion ameliorated this colitis (Garrett et al., 2007),
it did not affect fecal levels of either of these two bacterial
species (Figure 4B). These results demonstrate that K. pneumo-
niae and P. mirabilis levels are not simply associated with inflam-
mation, as both these modalities reduced host inflammation
but did not uniformly alter Enterobacteriaceal representation.
Our results illustrate that certain host-directed treatments may
exert their effects not only by altering host inflammatory
pathways but also by directly impacting the microbiota.
To begin to identify cell-based mechanisms by which TRUC-
derived Enterobacteriaceae elicit a host immune response,
TNF-a production wasmeasured in T-bet/Rag2/MyD88/
bone marrow-derived DCs cocultured with the K. pneumoniae
and P. mirabilis TRUC strains, as DCs and TNF-a production
are key features of the immunopathogenesis in TRUC mice,
and the TRUC inflammatory response is independent of
MyD88 (Garrett et al., 2007, 2009). Both live and heat-killed
bacteria stimulated TNF-a production from T-bet-, Rag2-, and
MyD88-deficient DCs (Figure 4C). These latter findings set
the stage for future bacterial cell fractionation experiments
where the microbial molecular determinants of host responses
can be characterized using in vitro systems composed of
genetically manipulated immune cells.
DISCUSSION
Defining microbial features that are associated with or initiate
IBD is complicated by host genetics, inflammatory state, and
diet (Peterson et al., 2008). Designing prospective studies in
human IBD to identify microbial communities that instigate
inflammation has not been feasible, even in genetically suscep-
tible populations. Thus, we performed a time series screen in a
mouse model of IBD that shares several pathophysiologic
features of human IBD, including immunodeficiency, compro-
mised host barrier function, and hyperimmunity, to characterize(D) Left panel: K. pneumoniae and P. mirabilis fecal cfu in Rag2/ and WT mic
P. mirabilis, K. pneumoniae, or a combination of both P. mirabilis and K. pneum
in Figure 1). Right panel: Histologic scores for colitis as assayed at sacrifice at 10
p values shown were calculated by the Mann-Whitney test.
Cell Host &a colitogenic microbiota. We established that host genotype
influenced the global structure of the associated microbial
community detected in feces and observed a number of
significant order- and species-level differences. Combined
with culture-dependent methods, we were able to identify
bacterial species whose role we could test in the development
of disease. Our experiments demonstrate that K. pneumoniae
and P.mirabilis, together with other members of the endogenous
microbiota, can elicit colitis even in WT mice. It will be important
to determine if significant associations are noted between these
Enterobacteriaceae species and ulcerative colitis or Crohn’s
disease in ongoing (e.g., Qin et al., 2010) and future metage-
nomic studies of gut microbial ecology in various populations
of patients with IBD.
K. pneumoniae and P. mirabilis can colonize mouse and
human intestine (Lau et al., 2008). Notably, we only recovered
these microbes from TRUC mice in our colony, not in Rag2/
or WT animals. While there was individual variation in bacterial
counts, the colonization pattern of these species across the
TRUC population over time was not significantly different and
did not vary as colitis worsened with age. Inciting inflammation
with dextran sulfate sodium in WT mice in the colony did not
result in an emergence of these bacteria. In contrast, Abx treat-
ment had a dramatic effect on the degree of host colonization
with K. pneumoniae and P. mirabilis, as expected. The increased
counts observed in response to vanco suggest that in the
untreated host, members of the Gram-positive flora affect the
degree of colonization by members of the Enterobacteriaceae.
A key feature of the colonic inflammation in TRUC mice is
elevated TNF-a. While both neutralizing antibodies and T-reg
infusion reduce mucosal TNF-a levels, these interventions had
disparate effects onK. pneumoniae and P. mirabilis fecal counts.
Cytokinesmay interactwith bacteria, and TNF-a has been shown
to affect Salmonella typhimurium replication in vivo (Romanova
et al., 2002).While TNF-adid not appear to affect the proliferation
of TRUC-derived K. pneumoniae and P. mirabilis in vitro, in vivo
there were significant effects in response to TNF-neutralizing
antibodies. Neutralizing antibodies and infusion of T-regs both
lower TNF-a levels in TRUC mice, but through different mecha-
nisms. T-regs also produce both IL-10 and TGF-b (Izcue et al.,
2009). T-regs and neutralizing antibodies may have direct but
distinct effects on microbial populations or indirect effects
through their differential effects on colonic DCs.
Opportunistic infection with K. pneumoniae and P. mirabilis is
well recognized in the respiratory and urinary tracts. However,
Klebsiella oxytoca but not K. pneumoniae has been tied to intes-
tinal pathology (Ho¨genauer et al., 2006). Klebsiella and Proteus
species are observed more frequently in the stool of ulcerative
colitis patients than healthy controls (Dorofeyev et al., 2009;
Kanareykina et al., 1987), and elevated titers of Enterobacteriaceal
antibodieshavebeen reported in IBDpatients (Cooper et al., 1988;
Ibbotson et al., 1987; Tiwana et al., 1998). Genome sequencing of
these isolates and comparisons to other sequenced isolates ob-
tained from other body and environmental habitats could yielde treated every other day from 2 to 10 weeks of age with 107 cfu of E. coli,
oniae added to their drinking water (all strains isolated from the TRUC mother
weeks of age. Each circle represents a separate animal in the treatment group.
Microbe 8, 292–300, September 16, 2010 ª2010 Elsevier Inc. 297
Figure 4. K. pneumoniae and P. mirabilis
Colonization Patterns Change in Response
to Immunotherapies, and Both Strains
Induce TNF-a Production in T-bet–/–
Rag2–/– MyD88–/– Bone Marrow-Derived
DCs
(A) Immunotherapy by TNF-a blockade alters
levels of culturable fecal Enterobacteriaceae.
TRUC mice were treated with anti-TNF-a
(15 mg/kg every week) (open circles) or isotype
control (shaded circles) for 4 weeks, and then
therapy was stopped. Enterobacteriaceae levels
were defined by culture of fecal samples obtained
1 day before, during, and after treatment (up to
14weeks of age). Circles represent themean value
of anti-TNF-a mice (n = 10) and isotype controls
(n = 10). Error bars represent 1 SD.
(B) Immunotherapy by T-reg infusion does not
produce statistically significant differences in the
levels of culturable Enterobacteriaceae species
compared to vehicle-treated controls. TRUC
mice were injected once with 75,000 T-regs
(n = 10) or PBS (n = 9).
(C) TNF-a production from T-bet/ Rag2/
MyD88/ bone marrow-derived DCs cocultured
with heat-killed and live K. pneumoniae and
P. mirabilis strains. Bars represent the mean value
of triplicate determinations/sample. Error bars
are 1 SD. Data are representative of three inde-
pendent experiments.
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their ability to drive development of an IBD phenotype. Future
studies can take advantage of the fact that both heat-killed and
live K. pneumoniae and P. mirabilis induce TNF-a in T-bet/
Rag2/MyD88/DCs to identify the responsible bacterialmole-
cules and their host receptors. However, it is important to also
emphasize that an endogenous microbial community is required
forK.pneumoniaeandP.mirabilis toexert their colitogeniceffects.298 Cell Host & Microbe 8, 292–300, September 16, 2010 ª2010 Elsevier Inc.Gut microbes help to structure the
mucosal immune system, and the
mucosal immune system shapes micro-
bial community structure (Smith et al.,
2007; Hooper and Macpherson, 2010).
Microbial community members may be
needed for the development of particular
immune subsets or appropriate localiza-
tion of immune cell subsets within the
mucosa to generate proinflammatory
responses to K. pneumoniae and
P. mirabilis. For example, adherent cecal
segmented filamentous bacteria have
recently been shown to play a central
role in the development of IL-17-
producing CD4+ T helper cells in mice
(Ivanov et al., 2009; Gaboriau-Routhiau
et al., 2009). CD11c+ DCs are necessary
for TRUC colitis (Garrett et al., 2007,
2009), and lamina propria CD11c+
CX3CR1+ DCs are markedly reduced in
germ-free mice (Niess and Adler 2010).In addition, interactions between K. pneumoniae and P. mirabilis
and microbial community members may result in the acquisition
of traits by these two Enterobacteriaceae (e.g., invasion) or by
other community members that elicit intestinal inflammation.
Convergence of host genetic susceptibility and microbial
community features could also affect the behavior of these En-
terobacteriaceae and the immune response to them, as we
have observed in the TRUC model.
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izing antibodies are common to both human IBD and several
experimental colitis models. Host factors, like elevated TNF-a,
may have virulence-promoting effects on these microbes. This
notion is not without precedent, as the Pseudomonas aeruginosa
protein OprF binds the proinflammatory cytokine IFN-g, resulting
in expression of PA-I lectin, a quorum sensing-dependent
virulence determinant (Wu et al., 2005).
In summary, future studies need to be directed at defining
the genomic features of TRUC-associated K. pneumoniae and
P. mirabilis strains, identifying co-occurring culturable members
of the microbiota that contribute to disease pathogenesis in
conventionally raised and gnotobiotic mousemodels, character-
izing host factors that drive these microbes to become colito-
genic, and determining the microbial-associated molecular
patterns and pattern recognition receptors involved in sponta-
neous and transmitted TRUC colitis. Together, these efforts
may provide mechanistic insights about how gut microbial
communities, working in concert with specific colitogenic
agents, contribute to initiation and perpetuation of IBD in
susceptible human hosts and provide the foundation for proof-
of-concept tests of preventative or therapeutic measures. An
additional benefit may be to help elucidate the association
between IBD and increased risk for tumorigenesis, since the
majority of TRUCmice spontaneously develop colonic dysplasia
and rectal adenocarcinoma (Garrett et al., 2009).
EXPERIMENTAL PROCEDURES
Husbandry of Conventionally Raised Mice
Rag2/, T-bet/3 Rag2/, andMyD88/3 T-bet/3Rag2/mice and
their genotyping have been described (Garrett et al., 2009). Mice were housed
inmicroisolator cages in a barrier facility at the Harvard School of Public Health
under a 12 hr light cycle.
16S rRNA-Based Analyses of Fecal Microbial Communities
Community DNA Preparation
Fecal samples were flash frozen on collection and stored at 80C before
processing. DNA was extracted by bead-beating as described (Turnbaugh
et al., 2009).
Sequencing and Analysis of 16S rRNA Gene Amplicons
The V2 region (primers 8F-338R) of bacterial 16S rRNA genes was targeted for
amplification and multiplex pyrosequencing with error-correcting barcodes
(Hamady et al., 2008). A total of 75,145 high-quality reads were generated
from 32 samples (2348 ± 343 reads per sample). See also Supplemental
Experimental Procedures.
Culture-Based Studies of Fecal Microbial Community Structure
Stool Collection
A minimum of three fecal pellets was collected from each mouse in a laminar
flow hood. Each mouse (three females/genotype; TRUC and Rag2/) was
sampled every 2 weeks at the same time of day from 2 to 10 weeks of age.
Mothers were sampled once when their pups were 2 weeks old.
Culture
Fecal pellets were collected into tubes of PBS with 0.05% cysteine HCl.
Serial 10-fold dilutions were made and plated on nonselective media and
selective media. Anaerobes were incubated at 37C in a Coy Anaerobic
chamber for a minimum of 5 days. Aerobes were incubated for 24–48 hr
at 37C.
Fecal Collection and Culture of Gram-Negative Aerobes
Mice were singly placed in autoclaved plastic cages. Four to six pellets were
collected/ mouse/ time point. Rag2/mice in Figure 2F were sampled twice
over a 3 day period for each weekly time point. Pellets were resuspended inCell Host &sterile PBS; 10-fold serial dilutions were generated, plated on MacConkey’s
medium, and incubated in ambient air at 37C overnight. The lower limit of
detection for these studies was 104.4 cfu/gram fecal dry weight.
Histology
Colons were harvested and prepared for histology as described (Garrett et al.,
2007). See Supplemental Experimental Procedures for more detail.
Antibiotic Treatment
Mice were treated with the following Abx dissolved in their autoclaved drinking
water as indicated: ampicillin (1 g/l; Roche), vancomycin (500 mg/l; Sigma),
neomycin sulfate (1 g/l; Sigma), metronidazole (1 g/l; Sigma; solubilized with
15 ml of 0.1 N acetic acid/l), and gentamicin (2 g/l; Cell Gro). Fluid intake
was monitored.
Fluorescence In Situ Hybridization
Colons harvested from 16 Rag2/ and 15 TRUC (3- to 8-week-old) mice were
fixed in Carnoy’s solution overnight and embedded in paraffin, and 5 mm thick
sections prepared (Swidsinski et al., 2005). The sequences of the following
FISH probes were obtained from probeBase (http://www.microbial-ecology.
net/probebase/) (Loy et al., 2007): the ‘‘universal’’ bacterial probe-EUB338
(pB-00159), Enterobacteriaceae targeted probe (pB-00914), K. pneumoniae-
directed probe (pB-00352), and P. mirabilis probe (pB-02110).
Cross-Fostering
On the day of birth, themother was removed from the birthing cage and placed
in a clean cage. A litter of pups with the designated genotype was then put into
the cage. Pups were weaned on postnatal day 21 (Garrett et al., 2007).
Gnotobiotic Mouse Experiments
All protocols related to the generation and husbandry of germ-free mice were
approved by the Washington University (Wash U) Animal Studies Committee.
Conventionally raised SPF T-bet/3 Rag2/mice were rederived as germ-
free in the gnotobiotic facility at Wash U. Subsequent experiments were
carried out at the Harvard Digestive Disease Center (HDDC) gnotobiotic
facility. Five mice were maintained germ-free, and another five mice (3 female
and 2 male) were cocolonized by introducing 4.8 3 108 cfu of K. pneumoniae
and 9.2 3 108 cfu of P. mirabilis into their oral cavity and simultaneously
spreading an equivalent amount of organisms on their fur and anus. See
Supplemental Experimental Procedures for more detail.
Invasion Experiments
K. pneumoniae,P.mirabilis, E. coli, or bothK. pneumoniae andP.mirabilis (23
107 cfu each; all isolated from the TRUC mother in Figure 1) were instilled into
the oral cavity of each mouse using a sterile pipette tip, and 1 3 107 cfu was
placed into a new container of their drinking water every other day.
Anti-TNF-a Treatment
Mice were injected with anti-TNF-a (clone TN3-19.12), a hamster anti-mouse
TNF-a-neutralizing IgG1 antibody, and control Ab (hamster anti-GST IgG1)
(Leinco Technologies, St. Louis) (15 mg/kg) once a week for 4 weeks (Garrett
et al., 2007).
Adoptive Transfer of T-Regulatory Cells
FACS-sorted lymph node CD4+ CD62Lhi CD25+ cells (T-reg, 75,000 cells) or
PBS were injected per mouse at 4 weeks of age (n = 10 for T-regs; n = 9 for
PBS) (Garrett et al., 2007). This experiment was terminated by euthanasia at
12 weeks because two control group mice became moribund from colitis.
Coculturing Bone Marrow-Derived Dendritic Cells
and Bacterial Strains
Mouse bone marrow-derived DCs were generated as described (Garrett et al.,
2007) and purified using anti-mouse CD11c-coupled magnetic beads.
K. pneumoniae or P. mirabilis was cocultured with DCs at a ratio of 1 cfu/DC
for 4 hr at 37C in a cell culture incubator at 5% CO2. Gent (50 mg/ml) was
then added to the media for 1hr, and cells were collected, washed, and incu-
bated with medium containing gent (20 mg /ml) for an additional 16 hr. Bacteria
were also heat-killed (incubation at 100C for 3 min followed by plating toMicrobe 8, 292–300, September 16, 2010 ª2010 Elsevier Inc. 299
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The Gut Microbiota and TRUC Colitisconfirm killing) and added to cultures of DCs at ratios of 1:1, 10:1, and 100:1.
Cells were cocultured for 20 hr. TNF-a levels in supernatants collected from
centrifuged live and heat-killed cocultures were determined using the mouse
OptEIA ELISA kit (BD Biosciences) and expressed as ng/ml/1 3 106 DCs.
Statistical Analysis
The Prism graphing and analysis program was used for calculation of
statistical measures including mean values, standard deviations, p values
(Mann-Whitney test), and two-way ANOVA.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
Supplemental References, two tables, and four figures and can be found
with this article online at doi:10.1016/j.chom.2010.08.004.
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